I like to find "the next big thing" that no one else sees.
Then I position early in quality speculations ahead of the trend.
It's how I've been able to find serial success in the publishing and early-stage funding space - what some would call venture capital - for a decade now.
I think I know what the next big thing is. And I'm now making my early speculations.
But when I say early... I mean early.
It's the only way to consistently net speculative returns that are in the realm of 10 times your money.
Over the years, I've been able to spot several such trends and lead my followers to those types of gains.
Back in 2008 - a decade before the Tesla hype - I was telling readers to position in Chinese battery and electric vehicle plays. One of our early speculations was BYD Co. (HK: 1211)(OTC: BYDDF).
We entered that play in December 2008 at HK$11.36. That was ahead of an entire generation of traders and 969% ago.
Later, in 2015, the trend was lithium (because electric cars can't power themselves so then we needed to find the Saudi Arabia of Lithium).
Find it, I did. We had several multi-bagger exits in lithium as a mini-bubble ensued, but the standout was Lithium X, which we entered at C$0.15. It was taken out five months later by a Chinese firm for C$2.61 - or 1,640% more than our entry price.
After that, I started looking into antibodies as a "next big thing" after seeing AbbVie's early success with Humira, the first widely successfully antibody-based drug. With the scientific name "Adalimumab" - the "ab" at the end stands for AntiBody - it was the number-one-selling drug in 2015 (US$14B) and 2016 ($16B).
You'll Never Be On The Inside!
So join Outsider Club today for FREE. You'll learn how to take control of your finances, manage your own investments, and beat "the system" on your own terms. Become a member today, and get our latest free report: "The Cryptocurrency Investor: How to Mint 21st Century Profits."
We never spam! View our Privacy PolicyAfter getting your report, you'll begin receiving the Outsider Club e-Letter, delivered to your inbox daily.
Any company that could successfully generate human antibody candidates for drug development was going to have great success.
Enter ImmunoPrecise Antibodies (TSX-V: IPA)(OTC: IPATF), a company I funded privately in 2016 and began recommending once it went public.
It is now up several hundred percent as it has discovered COVID-neutralizing antibodies that are now in preclinical trials. The CEO was invited on Bloomberg this week as shares hit 52-week highs. And I think they're headed higher.
But what I think is coming next has more to do with electrification and digitization.
Electric vehicles, batteries, and 5G have been all the rage on the Street... but something has to power it all.
What's the best speculation for this coming digital revolution?
Increasingly, I'm convinced it has to do with the processing power behind it all. Behind every electric car, 5G deployment, cryptocurrency, app, or e-game... there is a server somewhere processing it all.
The unknown secret is that servers are currently inefficient and powered with sub-optimal electricity. I expect this to change quickly, just like batteries in 2008 and lithium in 2015.
Like the search was on then for high-quality battery companies and high-quality lithium plays...
The search is on now for fast, clean servers.
Call it like you see it,
Nick Hodge
Nick is the founder and president of the Outsider Club, and the investment director of the thousands-strong stock advisories, Early Advantage and Wall Street's Underground Profits. He also heads Nick's Notebook, a private placement and alert service that has raised tens of millions of dollars of investment capital for resource, energy, cannabis, and medical technology companies. Co-author of two best-selling investment books, including Energy Investing for Dummies, his insights have been shared on news programs and in magazines and newspapers around the world. For more on Nick, take a look at his editor's page.